Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
The risk and clinical significance of cardiac iron overload due to chronic transfusion varies with the underlying disease. Cardiac iron overload shortens the life expectancy of patients with thalassemia, whereas its effect is unclear in those with myelodysplastic syndromes (MDS). In patients with si...
Main Authors: | Mariane de Montalembert, Jean-Antoine Ribeil, Valentine Brousse, Agnes Guerci-Bresler, Aspasia Stamatoullas, Jean-Pierre Vannier, Cécile Dumesnil, Agnès Lahary, Mohamed Touati, Krimo Bouabdallah, Marina Cavazzana, Emmanuelle Chauzit, Amandine Baptiste, Thibaud Lefebvre, Hervé Puy, Caroline Elie, Zoubida Karim, Olivier Ernst, Christian Rose |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5336214?pdf=render |
Similar Items
-
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
by: Marion Divoux, et al.
Published: (2020-09-01) -
Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease.
by: Isabelle Halphen, et al.
Published: (2014-01-01) -
Coexistent sickle-cell anemia and autoimmune disease in eight children: pitfalls and challenges
by: Valerie Li-Thiao-Te, et al.
Published: (2018-01-01) -
Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease
by: Guillaume Feugray, et al.
Published: (2022-10-01) -
Crosstalk between Acidosis and Iron Metabolism: Data from In Vivo Studies
by: Raêd Daher, et al.
Published: (2022-01-01)